ABR-217620

· Active Biotech AB

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABR-217620, covering 2014-08-27 to 2014-08-27. Get the full timeline:

Most recent: Clinical Trial Update: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer [Phase 1]

See pricing